RxDoctor Payments Data

Thomas Walsh, MD

Urology · Seattle, WANPI 1730274689

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (44.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 93.6% of it on its own, with 3 other manufacturers making up the rest. Among urology clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$185,690in general payments, 2019–2025

Across 323 payments — averaging $574.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$174K
  • Coloplast$12K
  • Laborie Medical Technologies Corp.$229
  • Procept Biorobotics Corporation$115
$202,361in research payments, 2019–2025

Across 30 payments — averaging $6745.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$181K
  • Endo USA, Inc.$22K

What the payments were for

  • Consulting fees$65,75035%
  • Speaking & faculty fees$82,83345%
  • Grants$1,9381%
  • Travel & lodging$28,16115%
  • Food & beverage$7,0084%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$185,690 in reported general payments places this provider in the 95th percentile of 274 urology providers in Washington.

See all urology providers in Washington

Medicare billing

Part B allowed, 2024
$42,509
Medicare patients
108
Services billed
215

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pentoxifylline19$923

Paid to pharmacies, not to this prescriber.

Other urology in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →